Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
0.303
-0.009 (-2.88%)
At close: Nov 20, 2024, 4:00 PM
0.296
-0.007 (-2.31%)
Pre-market: Nov 21, 2024, 7:15 AM EST
Venus Concept Market Cap
Venus Concept has a market cap or net worth of $2.20 million as of November 21, 2024. Its market cap has decreased by -80.88% in one year.
Market Cap
2.20M
Enterprise Value
36.58M
1-Year Change
-80.88%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since October 12, 2017, Venus Concept's market cap has decreased from $278.20M to $2.20M, a decrease of -99.21%. That is a compound annual growth rate of -49.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 2.20M | -66.15% |
| Dec 29, 2023 | 6.50M | -69.91% |
| Dec 30, 2022 | 21.60M | -76.55% |
| Dec 31, 2021 | 92.10M | 29.35% |
| Dec 31, 2020 | 71.20M | -48.92% |
| Dec 31, 2019 | 139.40M | 687.57% |
| Dec 31, 2018 | 17.70M | -86.70% |
| Dec 29, 2017 | 133.10M | -52.16% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 180 Life Sciences | 2.41M |
| HeartSciences | 2.41M |
| NanoVibronix | 2.39M |
| Scinai Immunotherapeutics | 2.31M |
| Fresh2 Group | 2.27M |
| Phio Pharmaceuticals | 2.20M |
| Xylo Technologies | 2.16M |
| Qualigen Therapeutics | 2.09M |